8-K: SeaStar Medical Secures $15 Million Stock Purchase Agreement with Lincoln Park Capital

Sentiment:

Current Report


SeaStar Medical Holding Corporation has entered into a purchase agreement with Lincoln Park Capital for up to $15 million in shares of common stock to bolster working capital and general corporate purposes.

Capital raiseSeaStar Medical has entered into a purchase agreement with Lincoln Park Capital for up to $15.0 million in shares of common stock.The company issued 236,406 shares of common stock to Lincoln Park as consideration for its commitment.The company intends to use the proceeds for working capital and general corporate purposes.

Summary

  • SeaStar Medical Holding Corporation has entered into a purchase agreement with Lincoln Park Capital Fund, LLC, for up to $15.0 million in shares of common stock.
  • Under the agreement, SeaStar Medical has the right, but not the obligation, to sell shares to Lincoln Park over a 36-month period, commencing upon the effectiveness of a registration statement.
  • SeaStar Medical issued 236,406 shares of common stock to Lincoln Park as consideration for its commitment.
  • The company intends to use the proceeds for working capital and general corporate purposes.
  • Regular purchases will be capped at 40,000 shares, but can increase to 50,000, 60,000, or 75,000 shares if the stock price is not below $1.00, $1.75, or $2.50, respectively, with a maximum commitment of $500,000 per purchase.
  • The purchase price for each regular purchase will be 97% of the lower of the lowest sale price on the purchase day or the average of the three lowest closing sale prices during the preceding 10-business day period.
  • SeaStar Medical may terminate the Purchase Agreement at any time after the Commencement Date, at no cost or penalty.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The agreement provides funding but also introduces potential dilution. It's a common financial maneuver for companies in SeaStar Medical's position.

Positives

  • The agreement provides SeaStar Medical with access to up to $15 million in capital.
  • The company has the flexibility to sell shares based on its funding needs and market conditions.
  • The agreement can be terminated by SeaStar Medical at any time after commencement without penalty.
  • The proceeds from the sales will be used for working capital and general corporate purposes.

Negatives

  • The sales of shares to Lincoln Park will dilute existing shareholders' equity.
  • The purchase price is set at a discount to the market price of the common stock.
  • The company may not issue or sell to Lincoln Park under the Purchase Agreement more than 19.99% of the shares of our common stock outstanding immediately prior to the execution of the Purchase Agreement unless certain conditions are met.

Risks

  • Sales of shares of common stock to Lincoln Park under the Purchase Agreement will depend on a variety of factors to be determined by us from time to time, including, among others, market conditions, the trading price of our common stock and our determination as to the appropriate sources of funding for our operations.
  • The company's stock price could be negatively impacted by the issuance of new shares.
  • The company's ability to access the full $15 million is subject to certain conditions and limitations.

Future Outlook

The company expects that any proceeds it receives from such sales will be used for working capital and general corporate purposes.

Industry Context

This type of financing agreement is common for small-cap companies seeking to raise capital. It provides flexibility but can also lead to stock dilution.

Comparison to Industry Standards

  • Comparable companies often use similar 'equity line of credit' facilities to access capital as needed.
  • The specific terms, such as the discount on the purchase price (3% in this case) and the commitment fee (236,406 shares), are within the typical range for these types of agreements.
  • The 19.99% Exchange Cap is a standard provision to avoid requiring shareholder approval under Nasdaq rules.

Stakeholder Impact

  • Shareholders may experience dilution of their ownership stake.
  • The company's employees and customers may benefit from the increased financial stability provided by the funding.
  • The company's suppliers and creditors may benefit from the company's improved financial position.

Next Steps

  • SeaStar Medical needs to file a registration statement with the SEC covering the resale of shares by Lincoln Park.
  • The company needs to satisfy the conditions outlined in Sections 7 and 8 of the Purchase Agreement to commence sales of shares.
  • The company needs to monitor the stock price to determine the appropriate number of shares to sell to Lincoln Park.

Key Dates

DateDescription
2025-03-27Date of Company's annual report on Form 10-K filed with the SEC.
2025-04-23Date of Company's Form 10-K/A filed with the SEC.
2025-04-25Date of the Purchase Agreement and Registration Rights Agreement with Lincoln Park Capital.
2025-07-31Outside date for Commencement to occur, after which either party may terminate the agreement.

Keywords

stock purchase agreement, Lincoln Park Capital, SeaStar Medical, common stock, financing, equity, shares

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.